Multi-Study R-Learner for Estimating Heterogeneous Treatment Effects Across Studies Using Statistical Machine Learning
跨研究异质性处理效应估计的多研究 R-learnerAI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要直接研究跨随机试验与观察研究的异质性处理效应估计及因果机器学习。
跨研究异质性处理效应估计的多研究 R-learnerAI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Estimating heterogeneous treatment effects (HTEs) is crucial for precision medicine. While multiple studies can improve the generalizability of results, leveraging them for estimation is statistically challenging. Existing approaches often assume identical HTEs across studies, but this may be violated due to various sources of between-study heterogeneity, including differences in study design, study populations, and data collection protocols, among others. To this end, we propose a framework for multi-study HTE estimation that accounts for between-study heterogeneity in the nuisance functions and treatment effects. Our approach, the multi-study R-learner, extends the R-learner to obtain principled statistical estimation with machine learning (ML) in the multi-study setting. It involves a data-adaptive objective function that links study-specific treatment effects with nuisance functions through membership probabilities, which enable information to be borrowed across potentially heterogeneous studies. The multi-study R-learner framework can combine data from randomized controlled trials, observational studies, or a combination of both. It's easy to implement and flexible in its ability to incorporate ML for estimating HTEs, nuisance functions, and membership probabilities. In the series estimation framework, we show that the multi-study R-learner is asymptotically normal and more efficient than the R-learner when there is between-study heterogeneity in the propensity score model under homoscedasticity. We illustrate using cancer data that the proposed method performs favorably compared to existing approaches in the presence of between-study heterogeneity.